CMMI 'hobbled,' data collection possibly aimless, researchers say

CMS Innovation Center
The CMS innovation center isn't living up to what lawmakers originally envisioned, according to three researchers. (CMS)

The CMS Innovation Center is being crippled by the Trump administration and might not be collecting the correct data from new payment models, according to a group of researchers. 

The focus on voluntary participation in programs by the Center for Medicare & Medicaid Innovation Center (CMMI) is hurting payment reform by possibly providing an inaccurate depiction of how such models will perform nationwide, researchers including Rahul Rajkumar, M.D., chief medical officer at Blue Cross Blue Shield of North Carolina, University of Michigan law professor Nicholas Bagley and Yale professor Scott Levy wrote in the New England Journal of Medicine.

"Voluntary programs don't always provide insight into whether a payment approach ought to be rolled out on a nationwide basis," they said. 

Conference

2019 Drug Pricing and Reimbursement Stakeholder Summit

Given federal and state pricing requirements arising, press releases from industry leading pharma companies, and the new Drug Transparency Act, it is important to stay ahead of news headlines and anticipated requirements in order to hit company profit targets, maintain value to patients and promote strong, multi-beneficial relationships with manufacturers, providers, payers, and all other stakeholders within the pricing landscape. This conference will provide a platform to encourage a dialogue among such stakeholders in the pricing and reimbursement space so that they can receive a current state of the union regarding regulatory changes while providing actionable insights in anticipation of the future.

While payment reform, like value-based care and population health, is popular throughout the healthcare sector, providers have been slow to adopt to changes and have pushed back on aggressive new payment changes. Those providers have found refuge in the Trump administration's approach, which has watered down or completely ended some mandatory programs.

The researchers specifically called out the administration's "backpedaling" of mandatory programs, like bundled payments for hip and femur fractures last year. Following the rollback, the agency, as expected, released a voluntary replacement bundle. 

Last fall, CMS Administrator Seema Verma called for industry input to guide the innovation center in a "new direction." 

RELATED: CMS unveils new voluntary bundled payment program 

The CMMI was initiated under the Affordable Care Act as a way to test payment models that have the potential to lower cost and improve patient outcomes. The researchers said the center is not living up to expectations.

Congress "would not have delegated to CMMI the extraordinary power to reshape Medicare and Medicaid while prohibiting the agency from amassing the highest-quality evidence about which models are effective," the authors wrote. 

The Department of Health and Human Services (HHS) has given mixed signals over the past year on how it plans to proceed with new CMMI models. Tom Price, President Donald Trump's original, and short-lived, HHS secretary strongly opposed mandatory models, while current secretary, Alex Azar, voiced more support. 

Last month, Azar appointed former Landmark Health CEO Adam Boehler to lead the Innovation Center.

RELATED: Most ACOs would flee Medicare program if pushed to take on more risk

CMS administrator Seema Verma has signaled that a larger quantity of voluntary programs is the best way to control costs by giving providers more choices, but one healthcare expert said that will only make things worse.

"The CMS has urged on the side of having too many programs and models, and its a little bit overwhelming for many organizations to try and keep up with and for the agency to manage," Michael Abrams, co-founder and managing partner of Numerof & Associates, told FierceHealthcare.

Abrams also agreed with the authors that voluntary models are not always reflective of how the entire industry will react to a new program. He added that fewer payment models provide a better focus on data, which would lead to better research on what programs work.

Suggested Articles

What are some of the biggest challenges for independent medical practices?

Researchers at two universities plan to develop an autonomous trauma care system that uses robotics and artificial intelligence to treat soldiers.

A change to the government’s voluntary bundled payment model for oncology is going to be bad news for many participants.